Compile Data Set for Download or QSAR
maximum 50k data
Found 112 with Last Name = 'zeng' and Initial = 'k'
TargetLysophosphatidic acid receptor 3(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177339(CHEMBL436763 | potassium ((2R,4R)-2-(heptadec-9-en...)
Affinity DataKi:  83nMAssay Description:Activity at LPA3 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 3(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177329(CHEMBL199380 | potassium (2-(6-(4-octylphenyl)hexy...)
Affinity DataKi:  171nMAssay Description:Activity at LPA3 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 3(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177340(CHEMBL382116 | potassium ((2R,4S)-2-(heptadec-9-en...)
Affinity DataKi:  241nMAssay Description:Activity at LPA3 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 1(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177336(CHEMBL373007 | potassium (2-(heptadec-9-enyl)-1,3-...)
Affinity DataKi:  497nMAssay Description:Activity at LPA1 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 1(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177331(CHEMBL381470 | potassium (2-dodecyl-1,3-dioxolan-4...)
Affinity DataKi:  652nMAssay Description:Activity at LPA1 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 2(Homo sapiens (Human))
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177331(CHEMBL381470 | potassium (2-dodecyl-1,3-dioxolan-4...)
Affinity DataKi:  745nMAssay Description:Activity at LPA2 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 2(Homo sapiens (Human))
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177331(CHEMBL381470 | potassium (2-dodecyl-1,3-dioxolan-4...)
Affinity DataKi:  745nMAssay Description:Activity at LPA2 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysophosphatidic acid receptor 1(Rattus norvegicus)
University Of Tennessee Health Science Center

Curated by ChEMBL
LigandPNGBDBM50177329(CHEMBL199380 | potassium (2-(6-(4-octylphenyl)hexy...)
Affinity DataKi:  1.93E+3nMAssay Description:Activity at LPA1 receptor in RH7777 rat hepatoma cell lineMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50396135(CHEMBL2171328)
Affinity DataIC50:  2nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50396135(CHEMBL2171328)
Affinity DataIC50:  2.04nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  3.20nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572022(US11447490, Compound 13)
Affinity DataIC50:  5.10nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  5.13nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594175(US11584745, Compound 17)
Affinity DataIC50:  5.20nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572027(US11447490, Compound 17a)
Affinity DataIC50:  6.60nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594172(US11584745, Compound 8)
Affinity DataIC50:  7nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572034(US11447490, Compound 22)
Affinity DataIC50:  7.40nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572010(BDBM572019 | US11447490, Compound 1)
Affinity DataIC50:  8nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572021(US11447490, Compound 12)
Affinity DataIC50:  8.5nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572012(US11447490, Compound 3)
Affinity DataIC50:  9.20nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594176(US11584745, Compound 18)
Affinity DataIC50:  9.40nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572020(US11447490, Compound 11)
Affinity DataIC50:  10nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594148(US11584745, Compound 1)
Affinity DataIC50:  13nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594180(US11584745, Compound 25)
Affinity DataIC50:  14nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572018(US11447490, Compound 9)
Affinity DataIC50:  15nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572010(BDBM572019 | US11447490, Compound 1)
Affinity DataIC50:  15nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  15.6nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572013(US11447490, Compound 4)
Affinity DataIC50:  17nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594169(US11584745, Compound 4)
Affinity DataIC50:  19nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594179(US11584745, Compound 23)
Affinity DataIC50:  21nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572016(US11447490, Compound 7)
Affinity DataIC50:  21nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572015(US11447490, Compound 6)
Affinity DataIC50:  25nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572024(US11447490, Compound 15)
Affinity DataIC50:  33nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572026(US11447490, Compound 17 | US11447490, Compound 20)
Affinity DataIC50:  34nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572014(US11447490, Compound 5)
Affinity DataIC50:  35nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50396135(CHEMBL2171328)
Affinity DataIC50:  38.9nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50396135(CHEMBL2171328)
Affinity DataIC50:  39nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572011(US11447490, Compound 2)
Affinity DataIC50:  44nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  45.7nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572025(US11447490, Compound 16)
Affinity DataIC50:  48nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50401095(CHEMBL2204447)
Affinity DataIC50:  49.7nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50401095(CHEMBL2204447)
Affinity DataIC50:  50.1nMAssay Description:Inhibition of horse AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50401095(CHEMBL2204447)
Affinity DataIC50:  53.7nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Electrophorus electricus (Electric eel))
Universit£T Regensburg

Curated by ChEMBL
LigandPNGBDBM50401095(CHEMBL2204447)
Affinity DataIC50:  53.9nMAssay Description:Inhibition of electric eel AChE by colorimetric Ellman assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572017(US11447490, Compound 8)
Affinity DataIC50:  56nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572032(US11447490, Compound 21)
Affinity DataIC50:  58nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594177(US11584745, Compound 19)
Affinity DataIC50:  75nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM594178(US11584745, Compound 20)
Affinity DataIC50:  76nMAssay Description:1xkinase buffer preparation: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT. Compound preparation: The final detection concentration of the c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572023(US11447490, Compound 14)
Affinity DataIC50:  78nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Shanghai Yingli Pharmaceutical

US Patent
LigandPNGBDBM572036(US11447490, Comparative compound 24)
Affinity DataIC50:  88nMAssay Description:1. Preparation of a 1× kinase buffer: 40 mM Tris (pH 7.5), 20 mM MgCl2, 0.10% BSA, 1 mM DTT.2. Compound preparation: The final detection concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 112 total ) | Next | Last >>
Jump to: